Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Edwards

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Expert Opinion on Investigational Drugs|April 7, 2010
Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancerJoanne Edwards
Translational Oncogenomics|May 4, 2013
The role of SRC family kinases in prostate cancerOleg Tatarov, Joanne Edwards
European Urology|February 20, 2007
Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cellsJoanne Edwards, Hing Y Leung
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2003
Mutation and polymorphism detection: a technical overviewJoanne Edwards, John M S Bartlett
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2003
Detection of microsatellite instability and loss of heterozygosity using DNA extracted from formalin-fixed paraffin-embedded tumor material by fluorescence-based multiplex microsatellite PCRJoanne Edwards, John M S Bartlett
BJU International|May 17, 2005
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathwaysJoanne Edwards, John M S Bartlett
BJU International|May 17, 2005
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptorJoanne Edwards, John M S Bartlett
Endocrine-Related Cancer|February 5, 2020
The NF-KB pathway and endocrine therapy resistance in breast cancerPhungern Khongthong, Antonia K Roseweir, Joanne Edwards
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|November 8, 2025
The epidemiology, current evidence and controversies in diagnosis and management of patients with colorectal peritoneal metastasesJohn Young, Joanne Edwards, James H Park
Clinical Science (London, England : 1979)|January 20, 2019
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancersJitwadee Inthagard, Joanne Edwards, Antonia K Roseweir
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Expert Opinion on Investigational Drugs|April 7, 2010
Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancerJoanne Edwards
Translational Oncogenomics|May 4, 2013
The role of SRC family kinases in prostate cancerOleg Tatarov, Joanne Edwards
European Urology|February 20, 2007
Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cellsJoanne Edwards, Hing Y Leung
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2003
Mutation and polymorphism detection: a technical overviewJoanne Edwards, John M S Bartlett
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2003
Detection of microsatellite instability and loss of heterozygosity using DNA extracted from formalin-fixed paraffin-embedded tumor material by fluorescence-based multiplex microsatellite PCRJoanne Edwards, John M S Bartlett
BJU International|May 17, 2005
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathwaysJoanne Edwards, John M S Bartlett
BJU International|May 17, 2005
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptorJoanne Edwards, John M S Bartlett
Endocrine-Related Cancer|February 5, 2020
The NF-KB pathway and endocrine therapy resistance in breast cancerPhungern Khongthong, Antonia K Roseweir, Joanne Edwards
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|November 8, 2025
The epidemiology, current evidence and controversies in diagnosis and management of patients with colorectal peritoneal metastasesJohn Young, Joanne Edwards, James H Park
Clinical Science (London, England : 1979)|January 20, 2019
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancersJitwadee Inthagard, Joanne Edwards, Antonia K Roseweir
Pageof 19